BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20001236)

  • 1. Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.
    Del Poeta G; Del Principe MI; Maurillo L; Rossi FM; Buccisano F; Ammatuna E; Simotti C; Zucchetto A; Catalano G; Bulian P; Bruno A; Venditti A; De Fabritiis P; Gattei V; Amadori S
    Leuk Lymphoma; 2010 Jan; 51(1):95-106. PubMed ID: 20001236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome.
    Kay S; Herishanu Y; Pick M; Rogowski O; Baron S; Naparstek E; Polliack A; Deutsch VR
    Cytometry B Clin Cytom; 2006 Jul; 70(4):218-26. PubMed ID: 16456869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
    Dürig J; Nückel H; Cremer M; Führer A; Halfmeyer K; Fandrey J; Möröy T; Klein-Hitpass L; Dührsen U
    Leukemia; 2003 Dec; 17(12):2426-34. PubMed ID: 14523469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
    Rossi FM; Del Principe MI; Rossi D; Irno Consalvo M; Luciano F; Zucchetto A; Bulian P; Bomben R; Dal Bo M; Fangazio M; Benedetti D; Degan M; Gaidano G; Del Poeta G; Gattei V
    J Transl Med; 2010 Mar; 8():23. PubMed ID: 20211015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
    Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia.
    Vroblova V; Smolej L; Krejsek J
    Hematology; 2012 Sep; 17(5):268-74. PubMed ID: 22971532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
    Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
    Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
    Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood lymphocyte phenotype of ZAP-70⁺ and ZAP-70⁻ patients with B-cell chronic lymphocytic leukaemia.
    Rivkina A; Holodnuka-Kholodyuk I; Murovska M; Soloveichika M; Lejniece S
    Exp Oncol; 2015 Mar; 37(1):73-6. PubMed ID: 25804237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia.
    Vener C; Gianelli U; Cortelezzi A; Fracchiolla NS; Somalvico F; Savi F; Pasquini MC; Bosari S; Deliliers GL
    Leuk Lymphoma; 2006 Feb; 47(2):245-51. PubMed ID: 16321853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.
    Ibrahem L; Elderiny WE; Elhelw L; Ismail M
    Blood Cells Mol Dis; 2015 Aug; 55(2):154-60. PubMed ID: 26142332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
    Passam F; Tachynopoulou V; Skoumi D; Tsompanakou A; Stavropoulos-Giokas A; Vadikolia C; Anagnostopoulos A; Paterakis G
    Ann Hematol; 2006 Nov; 85(11):795-805. PubMed ID: 16871389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.
    Nückel H; Switala M; Collins CH; Sellmann L; Grosse-Wilde H; Dührsen U; Rebmann V
    Clin Immunol; 2009 Jun; 131(3):472-80. PubMed ID: 19318232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry.
    Adams RL; Cheung C; Banh R; Saal R; Cross D; Gill D; Self M; Klein K; Mollee P
    Cytometry B Clin Cytom; 2014 Mar; 86(2):80-90. PubMed ID: 24127306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms.
    Carreras J; Villamor N; Colomo L; Moreno C; Ramón y Cajal S; Crespo M; Tort F; Bosch F; López-Guillermo A; Colomer D; Montserrat E; Campo E
    J Pathol; 2005 Mar; 205(4):507-13. PubMed ID: 15685592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.
    Bogner C; Sandherr M; Perker M; Weick K; Ringshausen I; Peschel C; Decker T
    Ann Hematol; 2006 Jul; 85(7):458-62. PubMed ID: 16538501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.
    Sheridan R; Mounajjed T; Ehrmann DE; Hurtubise PE; Schrager JA
    Cytometry B Clin Cytom; 2006 Jul; 70(4):320-1. PubMed ID: 16906578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.